Assessment and comparison of recovery after open and minimally invasive esophagectomy for cancer: An exploratory study in two centers

Annals of Surgical Oncology

Volumn 20, Issue 6, 2013, Pages 1970-1977

  Parameswaran, R ^a,b   Titcomb, D R ^c   Blencowe, N S ^c   Berrisford, R G ^a   Wajed, S A ^a   Streets, C G ^c   Hollowood, A D ^c   Krysztopik, R ^c   Barham, C P ^c   Blazeby, J M ^b,c  

^a ROYAL DEVON AND EXETER HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c UNIVERSITY HOSPITALS BRISTOL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; FLUOROURACIL;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER PATIENT; CANCER SURGERY; CLINICAL ASSESSMENT; CONTROLLED STUDY; CONVALESCENCE; DAILY LIFE ACTIVITY; DISEASE SEVERITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGUS CANCER; ESOPHAGUS DYSPLASIA; ESOPHAGUS RESECTION; EXPLORATORY RESEARCH; FATIGUE; FEMALE; HUMAN; KATZ SCALE; LAPAROSCOPIC ASSISTED ESOPHAGECTOMY; LAPAROSCOPIC SURGERY; LAWTON AND BRODY SCALE; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE ESOPHAGECTOMY; MINIMALLY INVASIVE SURGERY; MULTI DIMENSIONAL FATIGUE INVENTORY 20; MULTICENTER STUDY; OPEN ESOPHAGECTOMY; PATIENT SELECTION; PHYSICAL ACTIVITY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY; QUESTIONNAIRE; RATING SCALE; SURGICAL MORTALITY;

ACTIVITIES OF DAILY LIVING; ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD LOSS, SURGICAL; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; CISPLATIN; ESOPHAGEAL NEOPLASMS; ESOPHAGECTOMY; FATIGUE; FEMALE; FLUOROURACIL; HUMANS; LAPAROSCOPY; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; OPERATIVE TIME; QUESTIONNAIRES; SURGICAL PROCEDURES, MINIMALLY INVASIVE;

EID: 84878224499     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-012-2848-7     Document Type: Article

References (31)

1. The National Oesophago-Gastric Cancer Audit. http://www.augis.org/ clinical-audits/clinical-audits-og-cancer.htm. Accessed 8 Jan 2013.
2. Luketich JD, Alvelo-Rivera M, Buenaventura PO, Christie NA, McCaughan JS, Litle VR, et al. Minimally invasive esophagectomy: outcomes in 222 patients. Ann Surg. 2003;238:486-94.
3. Smithers BM, Gotley DC, Martin I, Thomas JM. Comparison of the outcomes between open and minimally invasive esophagectomy. Ann Surg. 2007;245:232-40.
4. Nagpal K, Ahmed K, Vats A, Yakoub D, James D, Ashrafian H, et al. Is minimally invasive surgery beneficial in the management of esophageal cancer? A meta-analysis. Surg Endosc. 2010;24:1621-9.
5. Parameswaran R, Blazeby JM, Hughes R, Mitchell K, Berrisford RG, Wajed SA. Health-related quality of life after minimally invasive oesophagectomy. Br J Surg. 2010;97:525-31.
6. Wang H, Feng M, Tan L, Wang Q. Comparison of the short-term quality of life in patients with esophageal cancer after subtotal esophagectomy via video-assisted thoracoscopic or open surgery. Dis Esophagus. 2010;23:408-14.
7. Weeks JC, Nelson H, Gelber S, Sargent D, Schroeder G; Clinical Outcomes of Surgical Therapy (COST) Study Group. Short-term quality-of-life outcomes following laparoscopic-assisted colectomy vs open colectomy for colon cancer: a randomized trial. JAMA. 2002;287:321-8.
8. King PM, Blazeby JM, Ewings P, Longman RJ, Kipling RM, Franks PJ, et al. The influence of an Enhanced Recovery Programme on clinical outcomes, costs and quality of life after surgery for colorectal cancer. Colorectal Dis. 2006;8:506-13.
9. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, Smith AM, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet. 2005;365:1718-26.
10. Kleinbeck SV, Eells KR. Monitoring postdischarge ambulatory surgical recovery costs and outcomes. Surg Serv Manage. 1997;3:33-5.
11. Oberle K, Allen M, Lynkowski P. Follow-up of same day surgery patients. A study of patient concerns. AORN J. 1994;59:1016-5.
12. Zalon ML. Correlates of recovery among older adults after major abdominal surgery. Nurs Res. 2004;53:99-106.
13. Blazeby JM, Blencowe NS, Titcomb DR, Metcalfe C, Hollowood AD, Barham CP. Demonstration of the IDEAL recommendations for evaluating and reporting surgical innovation in minimally invasive oesophagectomy. Br J Surg. 2011;98:544-51.
14. Berrisford RG, Wajed SA, Sanders D, Rucklidge MW. Short-term outcomes following total minimally invasive oesophagectomy. Br J Surg. 2008;95:602-10.
15. Medical Research Council Oesophageal Cancer Working Group. Surgical resection with or without preoperative chemotherapy in oesophageal cancer. Lancet. 2002;359:1727-33.
16. Medical Research Council. A randomised controlled trial comparing standard chemotherapy followed by resection versus ECX chemotherapy followed by resection in patients with resectable adenocarcinoma of the oesophagus. ISRCTN01852072. 2005.
17. Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg. 2009;250:187-96.
18. Katz S. Assessing self-maintenance: activities of daily living, mobility, and instrumental activities of daily living. J Am Geriatr Soc. 1983;31:721-7.
19. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969;9:179-86.
20. Smets EM, Garssen B, Bonke B, De Haes JC. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39:315-25.
21. Biere SS, van Berge Henegouwen MI, Maas KW, Bonavina L, Rosman C, Garcia JR, et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet. 2012;379:1887-92.
22. Briez N, Piessen G, Bonnetain F, Brigand C, Carrere N, Collet D, et al. Open versus laparoscopically-assisted oesophagectomy for cancer: a multicentre randomised controlled phase III trial - the MIRO trial. BMC Cancer. 2011;11:310.
23. Donovan J, Mills N, Smith M, Brindle L, Jacoby A, Peters T, et al. Improving design and conduct of randomised trials by embedding them in qualitative research: ProtecT (prostate testing for cancer and treatment) study. BMJ. 2002;325:766-70.
24. Metcalfe C, Blazeby JM, Berrisford R et al. ROMIO: Randomised Oesophagectomy: minimally invasive or open. Sydney: Health Technology Assessment Trial Funded; 2012.
25. Hulscher JB, van Sandick JW, de Boer AG, Wijnhoven BP, Tijssen JG, Fockens P, et al. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus. N Engl J Med. 2002;347:1662-9.
26. Blencowe NS, Strong S, McNair AG, Brookes ST, Crosby T, Griffin SM, et al. Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg. 2012;255:658-66.
27. Reynolds JV, McLaughlin R, Moore J, Rowley S, Ravi N, Byrne PJ. Prospective evaluation of quality of life in patients with localized oesophageal cancer treated by multimodality therapy or surgery alone. Br J Surg. 2006;93:1084-90.
28. Blazeby JM, Sanford E, Falk SJ, Alderson D, Donovan JL. Health-related quality of life during neoadjuvant treatment and surgery for localized esophageal carcinoma. Cancer. 2005;103:1791-9.
29. Bege T, Lelong B, Esterni B, Turrini O, Guiramand J, Francon D, et al. The learning curve for the laparoscopic approach to conservative mesorectal excision for rectal cancer: lessons drawn from a single institution's experience. Ann Surg. 2010;251:249-53.
30. Itani KM, Hur K, Kim LT, Anthony T, Berger DH, Reda D, et al. Comparison of laparoscopic and open repair with mesh for the treatment of ventral incisional hernia: a randomized trial. Arch Surg. 2010;145:322-8.
31. International Union Against Cancer. TNM Classification of Malignant Tumours. In: Sobin LH, Gospodarowicz MK, Wittekind C, editors. West Sussex, UK: Wiley-Blackwell; 2009.